Practical Approach to Cervical Squamous and Glandular Lesions
Krisztina Z. Hanley, MD
In 2012 American Cancer Society and its partner organizations updated the screening and management guidelines for women with abnormal cervicovaginal cytology. Recently consensus recommendations from the Lower Anogential Squamous Terminology (LAST) project were published to improve accuracy of histologic diagnosis and to provide optimal patient care in a setting of HPV-related squamous lesions of the lower anogential tract. This workshop will review the new screening recommendations and management guidelines for women with abnormal cytology. Changes from the 2006 guidelines will be highlighted by case based presentation. Emphasis will be on risk of disease progression in different age groups and clinical significance of HPV test results on patient management. The second part of the course will review the LAST terminology. Representative cytology (Pap smears) and corresponding histologic samples from the same cases will illustrate the different diagnostic categories. A special emphasis will be given on when and how to select biomarkers to improve accuracy and reproducibility of histologic diagnosis in cervical squamous lesions and selected glandular lesions.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Understand the relationship between screening diagnoses and risk of CIN3
- Review of clinical significance of positive high risk HPV test result in patient management
- Review selected aspects of the LAST terminology for squamous lesions of the cervix and utility of biomarkers for ancillary testing
- Review the diagnostic workup of challenging squamous and glandular lesions on Pap test using cell block and ancillary studies
- Review of current screening and management guidelines recommended by the USPSTF, and the collaboration of ASCP, ASCCP and ACS, for women with abnormal cervico-vaginal cytology. Guidelines pertinent to primary HPV screening will also be discussed
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Krisztina Z. Hanley, MD
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant